Richard Jove - Search Results

Year	Number of Results
2000	1
2002	14
2003	13
2004	10
2005	15
2006	7
2007	8
2008	11
2009	10
2010	7
2011	9
2012	13
2013	11
2014	7
2015	3
2016	8
2017	2
2018	5
2019	3
2020	2
2024	0

1

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.

Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, Somlo G, Jandial R, Ann D, Hanash S, Jove R, Yu H. Wang T, et al. Among authors: jove r. Cell Metab. 2018 Jan 9;27(1):136-150.e5. doi: 10.1016/j.cmet.2017.11.001. Epub 2017 Dec 14. Cell Metab. 2018. PMID: 29249690 Free PMC article.

2

Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Yu H, Lee H, Herrmann A, Buettner R, Jove R. Yu H, et al. Among authors: jove r. Nat Rev Cancer. 2014 Nov;14(11):736-46. doi: 10.1038/nrc3818. Nat Rev Cancer. 2014. PMID: 25342631 Review.

3

STATs in cancer inflammation and immunity: a leading role for STAT3.

Yu H, Pardoll D, Jove R. Yu H, et al. Among authors: jove r. Nat Rev Cancer. 2009 Nov;9(11):798-809. doi: 10.1038/nrc2734. Nat Rev Cancer. 2009. PMID: 19851315 Free PMC article. Review.

4

Differences and similarities between cancer and somatic stem cells: therapeutic implications.

Rossi F, Noren H, Jove R, Beljanski V, Grinnemo KH. Rossi F, et al. Among authors: jove r. Stem Cell Res Ther. 2020 Nov 18;11(1):489. doi: 10.1186/s13287-020-02018-6. Stem Cell Res Ther. 2020. PMID: 33208173 Free PMC article. Review.

5

Targeting STAT3 affects melanoma on multiple fronts.

Kortylewski M, Jove R, Yu H. Kortylewski M, et al. Among authors: jove r. Cancer Metastasis Rev. 2005 Jun;24(2):315-27. doi: 10.1007/s10555-005-1580-1. Cancer Metastasis Rev. 2005. PMID: 15986140 Review.

6

The STATs of cancer--new molecular targets come of age.

Yu H, Jove R. Yu H, et al. Among authors: jove r. Nat Rev Cancer. 2004 Feb;4(2):97-105. doi: 10.1038/nrc1275. Nat Rev Cancer. 2004. PMID: 14964307 Review. No abstract available.

7

Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.

Buettner R, Mora LB, Jove R. Buettner R, et al. Among authors: jove r. Clin Cancer Res. 2002 Apr;8(4):945-54. Clin Cancer Res. 2002. PMID: 11948098 Review.

8

Immunotherapy as part of a multidisciplinary approach to melanoma treatment.

Riker AI, Jove R, Daud AI. Riker AI, et al. Among authors: jove r. Front Biosci. 2006 Jan 1;11:1-14. doi: 10.2741/1775. Front Biosci. 2006. PMID: 16146709 Review.

9

Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.

Haura EB, Turkson J, Jove R. Haura EB, et al. Among authors: jove r. Nat Clin Pract Oncol. 2005 Jun;2(6):315-24. doi: 10.1038/ncponc0195. Nat Clin Pract Oncol. 2005. PMID: 16264989 Review.

10

Activated stat-3 in melanoma.

Messina JL, Yu H, Riker AI, Munster PN, Jove RL, Daud AI. Messina JL, et al. Among authors: jove rl. Cancer Control. 2008 Jul;15(3):196-201. doi: 10.1177/107327480801500302. Cancer Control. 2008. PMID: 18596671 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year